Form 4: MACE ELIZABETH B. reports acquisition/exercise transactions in BKD

Rhea-AI Filing Summary

MACE ELIZABETH B. reported acquisition or exercise transactions in a Form 4 filing for BKD. The filing lists transactions totaling 9,810 shares. Following the reported transactions, holdings were 41,265 shares.

Insider Trade Summary

Net Buyer: 9,810 shares

Net Buy 1 txn

Insider MACE ELIZABETH B.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	9,810	$0.00	$0.00

Holdings After Transaction: Common Stock — 41,265 shares (Direct)

Footnotes (1)

1. F1. Grant of unrestricted shares of Common Stock under the Brookdale Senior Living Inc. 2024 Omnibus Incentive Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 02/17/2026 - 04:52 PM Learn about SEC filing dates

FAQ

What insider transaction did Brookdale Senior Living (BKD) report for Elizabeth B. Mace?

Brookdale reported that director Elizabeth B. Mace received a grant of 9,810 shares of common stock. The award was made on February 12, 2026 as unrestricted stock under the company’s 2024 Omnibus Incentive Plan, reflecting equity-based director compensation.

Was the Brookdale (BKD) Form 4 transaction a stock purchase or a grant?

The Form 4 shows a grant, not a market purchase. Elizabeth B. Mace acquired 9,810 Brookdale common shares at $0 as an unrestricted stock award under the 2024 Omnibus Incentive Plan, classified under transaction code A for a grant or other acquisition.

How many Brookdale (BKD) shares does Elizabeth B. Mace own after this Form 4 transaction?

After the reported equity grant, Elizabeth B. Mace beneficially owns 41,265 shares of Brookdale common stock. The filing classifies this as direct ownership, meaning the shares are held in her name rather than through an indirect entity or intermediary arrangement.

What is the price per share for the Brookdale (BKD) stock grant to Elizabeth B. Mace?

The grant to Elizabeth B. Mace was reported at a price of $0 per share. This indicates a compensatory award of 9,810 unrestricted Brookdale common shares rather than a cash-funded purchase, consistent with typical equity grants under incentive compensation plans.

Under which plan was the Brookdale (BKD) stock granted to Elizabeth B. Mace?

The shares were granted under the Brookdale Senior Living Inc. 2024 Omnibus Incentive Plan. The Form 4 footnote specifies that the 9,810 common shares are unrestricted stock awarded pursuant to this plan as part of director compensation arrangements.

What does transaction code “A” mean in the Brookdale (BKD) Form 4 for Elizabeth B. Mace?

Transaction code “A” on the Form 4 denotes a grant, award, or other acquisition. For Elizabeth B. Mace, it refers to the acquisition of 9,810 unrestricted Brookdale common shares as a stock grant, rather than an open-market buy or sell transaction.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MACE ELIZABETH B.

(Last) (First) (Middle)

C/O BROOKDALE SENIOR LIVING INC.

105 WESTWOOD PLACE, SUITE 400

(Street)

BRENTWOOD TN 37027

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Brookdale Senior Living Inc. [ BKD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/12/2026		A(1)		9,810	A	$0	41,265	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of unrestricted shares of Common Stock under the Brookdale Senior Living Inc. 2024 Omnibus Incentive Plan.

Remarks:

	/s/ Chad C. White, By Power of Attorney	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.